Clinmark | Top Contract Research and Consulting Organisation in Europe 2026

MedTech Outlook Magazine

Clinmark
Optimising Clinical and Regulatory Execution at Scale

Marek Wasiluk, Clinmark | Medical Tech Outlook | Top Contract Research and Consulting Organisation in EuropeMarek Wasiluk, CEO
What challenges are shaping clinical and regulatory execution in today’s medical research environment?

Clinmark brings 25 years of industry experience to a clinical environment defined by rising scrutiny and shrinking tolerance for error. Its work centres on aligning clinical execution, regulatory strategy and quality oversight before problems surface.

How does Clinmark structure its services to integrate clinical, regulatory and quality functions effectively?

A full-service, quality-driven Brain CRO with a strong analytical focus, Clinmark has delivered more than 450 clinical research and consulting projects across 75 countries, supporting over 25,000 study subjects globally. It works with a range of sponsors, from large organisations with established internal teams to smaller companies navigating the European market for the first time.

As evidence thresholds increase and notified body capacity remains constrained, interpretations under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) continue to evolve. Clinmark responds with a single operating model integrating clinical research, regulatory consulting and quality oversight. It aligns planning, execution, analysis and advisory work across the clinical and regulatory lifecycle, from early feasibility and regulatory readiness through execution and post-market obligations.

This begins with internal training and regulatory awareness, translating regulatory theory into clinical application through standardised global procedures. Clinmark also emphasises active, case-specific dialogue with regulators to clarify evolving expectations.

“We are not only a CRO that executes, but one that plans, advises and analyses, translating regulatory theory into practical, real-life application,” says Marek Wasiluk, CEO.
Marta Rzeszotarska, Executive Vice President, Contract and Project Execution and Grzegorz Pogorzelski, MD, Executive Vice President, Strategy & Clinical Operations
A Quality-Led Global Operating Model

Why is a quality-led operating model critical for global clinical programme consistency and compliance?

Clinmark’s global operating model combines operational execution with centralised quality oversight, supported by ISO-aligned global management systems across Europe, the U.S. and Asia. This focus on quality management systems, regulatory consulting and GxP oversight shapes how clinical programmes are designed, executed and controlled.

Quality by design is central to this structure. While the concept has gained broader adoption across GxP environments in recent years, Clinmark implemented quality-by-design methodologies in clinical research years before they became regulatory expectations.

This approach embeds quality into study planning, execution and oversight, reducing reliance on corrective actions later in development.

Training underpins this operating model, enabling consistent delivery, predictable outcomes and uniform quality standards across regions and study types.

“Never compromise the quality in a world where the balance in the ecosystem of partners makes the difference between success and failure,” says Wasiluk.

Addressing Regulatory Gaps Early

In what way does early regulatory assessment help sponsors align with MDR and IVDR requirements?

With larger organisations, Clinmark’s role typically centres on execution and optimisation, working alongside established internal teams and defined regulatory strategies.

For smaller organisations, it begins with early-stage consulting and feasibility assessment to evaluate regulatory readiness, clinical strategy and market objectives. This reveals gaps between legacy approaches and current MDR and IVDR expectations, enabling sponsors to adjust assumptions, budgets, timelines or market entry plans.

In some cases, companies withdraw from the EU market due to complexity or cost. Clinmark ensures sponsors fully understand regulatory, clinical and post-market surveillance before proceeding.

Execution Shaped by Regulatory Reality

Clients choose Clinmark for its predictability, transparency and practical approach. It operates with pricing clarity and communicates feasibility, constraints and limitations early. Commitments are made only when delivery is realistically achievable, giving sponsors earlier clarity, fewer downstream resets and reduced rework as MDR and IVDR interpretations evolve.

  • We are not only a CRO that executes, but one that plans, advises and analyses, translating regulatory theory into practical, real-life application.


“With years of hands-on experience in the market, we provide practical guidance grounded in regulatory reality and tailored to each client’s operational capabilities,” says Marta Rzeszotarska, Executive Vice President, Contract and Project Execution.

Speed and professionalism are balanced with a collaborative working style that prioritises informed decision-making. Clinmark engages clients as partners, ensuring they understand regulatory decisions, clinical outcomes and how delivered work supports broader development and market objectives. This emphasis on education functions as a governance mechanism, enabling sponsors to understand what is delivered, why it is required and how it should be applied.

As regulatory complexity becomes the norm, Clinmark translates uncertainty into informed, defensible decisions. Its recognition as the Top Contract Research and Consulting Organisation in Europe reflects the predictability and security it provides sponsors operating under evolving regulatory expectations and increasing scrutiny.

Deep Dive

Selecting a Contract Research and Consulting Organisation under MDR and IVDR

European life sciences companies are navigating a regulatory climate defined by tighter evidence expectations, constrained notified body capacity and sustained scrutiny under MDR and IVDR. Clinical and regulatory functions that once operated in parallel now intersect at every stage of market access and post-market oversight. For executives......Read more

Contract Research and Consulting Organisation Info

Q1

Why is Clinmark recognized in the clinical research and consulting industry?

Clinmark has established a specialized presence in the Contract Research and Consulting Organizations sector through its focus on clinical research support, regulatory guidance and healthcare consulting services. The company works with organizations involved in healthcare and life sciences to support research activities, project coordination and compliance-focused development processes. Its approach to Contract Research and Consulting Organizations emphasizes technical expertise, structured project management and industry-focused consulting aligned with evolving clinical and regulatory requirements. By concentrating on research support and healthcare consulting, Clinmark continues to strengthen its relevance within the life sciences sector.

Q2

What differentiates Clinmark from other research and consulting providers?

Healthcare-focused consulting and research coordination distinguish Clinmark within the Contract Research and Consulting Organizations category. The company emphasizes collaborative project support, regulatory awareness and clinical development expertise designed to assist organizations navigating complex healthcare and research environments. Its service approach focuses on practical execution, compliance support and research efficiency rather than generalized business consulting. By aligning its Contract Research and Consulting Organizations services with the needs of healthcare and life sciences projects, Clinmark positions its expertise to support specialized clinical development initiatives.

Q3

How does Clinmark support healthcare and life sciences organizations?

Clinmark supports organizations through Contract Research and Consulting Organizations services designed to improve research coordination, project oversight and regulatory support within healthcare environments. The company emphasizes structured project execution, technical collaboration and consulting guidance to assist teams managing clinical and research-related activities. Its focus on operational consistency and healthcare expertise contributes to smoother project workflows and more dependable research support. This support-oriented approach helps organizations maintain confidence throughout development and consulting processes.

Q4

How do Clinmark’s services create value for clinical and research projects?

Technical guidance and coordinated research support contribute significantly to the value of Clinmark’s Contract Research and Consulting Organizations capabilities. The company’s services are intended to support healthcare and life sciences organizations seeking expertise in project management, clinical coordination and compliance-focused consulting. Attention to research quality and operational efficiency also helps align its support with the evolving priorities of healthcare development environments. Through its focus on clinical consulting and project support, Clinmark contributes to more effective research and development activities.

Q5

What role does innovation play in Clinmark’s consulting strategy?

Innovation remains central to Clinmark’s work within the Contract Research and Consulting Organizations market. The company incorporates evolving healthcare regulations, research methodologies and project management approaches into its consulting and support services to address changing industry expectations. Continuous attention to operational efficiency, regulatory alignment and clinical support helps Clinmark remain aligned with developments in healthcare research and consulting practices. This commitment to improvement supports the company’s long-term focus on life sciences project support and healthcare consulting excellence.

Q6

Why is Clinmark relevant to today’s healthcare and life sciences landscape?

Healthcare and life sciences organizations increasingly require specialized expertise to manage clinical development, regulatory processes and research coordination activities. Clinmark remains relevant because its Contract Research and Consulting Organizations services are designed to address these priorities through healthcare-focused consulting and structured research support. The company’s emphasis on project management, compliance guidance and clinical expertise aligns with the evolving needs of healthcare innovators and research-driven organizations. Its specialized approach continues to contribute to progress within modern clinical research and healthcare consulting environments.

Top Contract Research and Consulting Organisation in Europe 2026

Company
Clinmark

Management
Marek Wasiluk, CEO and Marta Rzeszotarska, Executive Vice President, Contract and Project Execution and Grzegorz Pogorzelski, MD, Executive Vice President, Strategy & Clinical Operations

Description
Clinmark is a full-service CRO and clinical consulting partner supporting pharmaceutical and biotech companies worldwide. By combining clinical trial execution, quality oversight and regulatory consulting, it helps sponsors plan and deliver efficient clinical programs, translating complex requirements into practical, cost- and time-optimized outcomes.